VD – IMS
Frequent outbreaks of new viruses have resulted in a growing variety of vaccines, but repeated registration errors at vaccination institutions persist due to manual data entry.
Adverse Reaction Self-Check
Recipients can check their condition through self-monitoring and receive vaccination with peace of mind.
Data Analysis & Utilization
Prediction of Vaccine Side Effects Meta-data algorithms are used to predict vaccine side effects related to underlying conditions.
Prevents vaccine safety accidents caused by incorrect administration
Reduces damage from secondary side effects through post-vaccination management
Enables remote medical services (consultation and care) after vaccination
Prevents medical staff’s mistakes (misadministration, misregistration) in advance
Increases insurance reimbursements through improved patient satisfaction
Reduces costs by automating vaccine usage processing
Blocks risk factors with automatic expiration date management (alerts and warnings)
Generates non-face-to-face profits through remote consultation for adverse reactions
- Serves as a solution for vaccine-phobia phenomena
- Generates and utilizes research and development material
- Reduces social costs by forecasting vaccine demand and decreasing waste
For medical advancement
- Contributes to global precision medicine by predicting vaccine side effects related to underlying conditions
- Supports large-scale clinical trials needed for new drug and vaccine development
- Builds a systematic approach to identifying and diagnosing widespread biomarkers of underlying diseases
- Elevates drug development precision medicine applications
- Uses AI-based biomarker analysis platforms for cancer, heart disease, and diabetes diagnosis and treatment, improving clinical trial success rates
Business Organizations
- Helps improve public health by managing national vaccinations for infants and children under age 12 (17 types, 36 doses)
- Supports technical export businesses with a system to manage adverse effects of mass vaccinations
- Drives commercialization and sales growth: stages of market expansion (10% market share in year 1, 30% in year 2, 60% in year 3)
